Director of Research Site Partnership

It’s More Than a Career, It’s a Mission. Our people are the foundation of our success. By joining our growing team at Sarah Cannon Research Institute (SCRI), a subsidiary of McKesson, you will have the opportunity to become part of one of the largest community-based cancer programs to advance oncology treatments and improve outcomes for cancer patients across the globe. We look for mission-driven candidates who have a desire to advance the fight against cancer and make a difference in the lives of patients diagnosed with cancer every day.

People who live with cancer – those who work to prevent it, fight it, and survive it – are at the heart of every decision we make. Bringing the most innovative medical minds together with the most passionate caregivers in their communities, we are transforming care and personalizing treatment. Through clinical excellence and cutting-edge research, SCRI is redefining cancer care around the world. As the Director of Research Site Partnerships  you serve as the executive relationship owner for a portfolio of oncology research sites. You will drive site engagement, alignment, and performance through strategic partnership and a focus on clinical trial enrollment growth. You will operate as a strategic account leader, navigating complex situations, influencing outcomes, and partnering across leadership to align priorities, remove barriers, and deliver value in a matrixed environment. Your responsibilities will include:  Manage a portfolio of approximately 5–6 oncology research sites, depending on complexity   Serve as senior relationship owner for assigned sites    Build executive-level partnerships with site leadership, physicians, research teams, and administrators    Develop and maintain understanding of site strategy, capabilities, and opportunities    Align enterprise strategy with site goals   Drive accountability for clinical trial enrollment performance    Analyze enrollment trends and identify growth opportunities    Develop and track strategic enrollment action plans    Promote best practices supporting accrual    Monitor and report on key performance indicators   Translate enterprise priorities into site-level strategies    Lead sites through change and transformation    Elevate trends and insights to leadership   Navigate high-impact or complex situations  Use negotiation and conflict resolution to achieve outcomes   Coordinate with internal teams to support site needs    Ensure alignment across stakeholders   Represent site perspectives in leadership forums    Identify opportunities to improve processes and engagement     You should have for this position:  Bachelor Degree required, master degree preferred  Experience supporting oncology research sites and clinical trial enrollment   Experience in site engagement, account management, or clinical operations   Must have experience in clinical research operations  Experience in oncology research  Strategic relationship management skills   Data analysis skills  Excellent communication skills  The ability to influence others  Experience operating in a matrixed environment  About Sarah Cannon Research Institute Sarah Cannon Research Institute (SCRI) is one of the world’s leading oncology research organizations conducting community-based clinical trials. Focused on advancing therapies for patients over the last three decades, SCRI is a leader in drug development. In 2022, SCRI formed a joint venture with former US Oncology Research to expand clinical trial access across the country. It has conducted more than 850 first-in-human clinical trials since its inception and contributed to pivotal research that has led to the majority of new cancer therapies approved by the FDA in the past decade. SCRI’s research network brings together more than 1,300 physicians who are enrolling patients into